Yahoo Finance

Oxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following closing of its deal with ...

Oxford, UK – 11 March 2022: Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or the “Company"), a leading gene and cell therapy group, is pleased to announce that it has completed its deal with ...
Electronic Design

Scalable Vector Extensions Expand the ARMv8-A's Scope

ARM’s Scalable Vector Extensions for the ARMv8-A architecture expands its scope to supercomputing and high performance embedded systems. ARMâ s Scalable Vector Extensions (SVE) for the ARMv8-A builds ...
Finanznachrichten

Oxford BioMedica plc: Oxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following ...

Unique platform offering capabilities from vector design and process development through to clinical trials is now available to new customers Oxford, UK - 11 March 2022: Oxford Biomedica plc (LSE:OXB) ...